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Abstract
Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with extensive structural, contractile, and
electrophysiological remodeling. In this manuscript we re-analyzed gene expression data from a microarray experiment on
AF patients and control tissues, using a new paradigm based on a posteriori unsupervised strategy in which the
discrimination of patients comes out from purely syntactical premises. This paradigm, more adherent to biological reality
where genes work in highly connected networks, allowed us to get both a very precise patients/control discrimination and
the discovery of cell adhesion/tissue modeling and inflammation processes as the main dimensions of AF.
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Introduction
Atrial fibrillation (AF) is the most common persistent cardiac
arrhythmia and also the most common cause of arrhythmia-
related hospitalizations [1,2]. It has an enormous societal impact
because of its very high incidence, its clinical consequences, the
difficulty of its diagnosis and management. Given that its incidence
increases with age and with life expectancies, increasing in both
developed and developing countries, AF is projected to become an
increasing burden on most health care systems [3].
The relative risk of death for people with AF is over 20% higher
peryearthanthatofage-matchedcontrols,withstrokeaccountingfor
the majority of that greater risk [4]. AF is also associated with
extensive structural, contractile, and electrophysiological remodeling,
which can sustain AF itself. Current pharmacological treatments of
AF present some limits because they can be ventricular proar-
rhythmic and not able to prevent recurrences of AF.
The understanding of the molecular events of these remodeling
processes is essential for the development of new targeted
therapeutic interventions so fostering a great deal of research in
the elucidation of the molecular bases of the disease.
Thus far, there has been a major focus on electrical components of
the remodeling process, which has been analyzed at the molecular
level by candidate gene approaches that have identified expression
changes in genes encoding ion channels or calcium-handling proteins
[5,6]. Some recent studies characterized the molecular basis of AF
remodeling on a more global scale, using genome-wide [7–10] and
dedicated [11] microarrays. All these studies used the classical
supervised statistical technique of hypothesis testing (detecting
differentially expressed genes one by one).
This approach, while surely providing an information easily
understandable to biologists who are used to think on a gene-by-
gene based, can be severely biased by the high dimensionality of
the microarray experiments provoking a lot of chance correlations
[12]. Moreover, on a physiological standpoint, the idea of genes
working independently (implicit in the supervised gene-by-gene
approach) is very unrealistic [13–15]. This is particularly cogent in
the case of cardiac arrhythmias such as atrial and ventricular
fibrillation that were demonstrated to be related to the feature of
multistability of cardiac tissues [16], an intrinsic property emerging
from the interaction of a multiplicity of different factors. New
paradigms are needed if we are to succeed in unravelling
multifactorial genetic causation at higher levels of physiological
function [17]. Thus we shifted to an a posteriori, unsupervised
approach relying on the application of principal component
analysis technique in both a clustering (oblique principal
components) and spectral (component extraction of the data set
having as variables the different tissues and as samples the
analyzed genes) mode [18].
Beside the discovery of a relevant inflammatory component in
addition to the already known cell adhesion/tissue remodeling
one, our approach allowed us to confirm the ‘attractor-like’
hypothesis of gene expression regulation and demonstrated a very
deterministic structure down to very minor regulation modules.
In a clinical perspective the very efficient patient/control
discrimination obtained opens the way for both a quantitative
estimation of disease gravity and efficacy of therapeutic interven-
tions.
Materials and Methods
A. Expression data
The data were obtained from the public functional genomics
data repository of the National Institute of Health (called Gene
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been analyzed, consisting of samples of right atrial myocardium
(appendage). Data were related to two Affymetrix platforms
U133A and U133B. Right atrial appendages were obtained from
30 patients undergoing open heart surgery for valve repair or
coronary artery bypass grafting. Of these, 10 patients had
permanent AF defined as duration of AF longer than 3 months
as documented by ECG, whereas 20 patients had no history of AF
and were in SR when open heart surgery was performed. Details
on clinical protocol and hybridization procedures can be found in
[10,13]. According to these previous publication, all patients gave
written informed consent.
B. Data analysis strategy
The data are organized in such a way to have the genes as
statistical units and the patients as variables. The genome-wide
expression profiles of each individual (variables), both AF and
control subjects, were clustered by a divisive clustering algorithm
based on Oblique Principal Component Analysis (OPCA, [19]).
The original data set is progressively subdivided in clusters with
the goal to cluster together maximally correlated variables. The
progressive division of the data set corresponds to the generation
of clusters of variables and to generate clusters the more
independent of each other: this is a maximum intra cluster
correlation/minimal inter clusters correlation criterion analogous
to the k-means procedure [19]. In this case, given the huge
between variables (genome wide profiles) correlation, the system
gives by default a single cluster solution (all the profiles pertaining
to the same cluster) explaining the 98.7% of total variance. This
result is consistent with the well known fact that any sample of a
particular tissue has a strongly invariant gene expression profile.
To check if an unsupervised clustering strategy was consistent with
normal vs pathology classification, we set a priori the number of
clusters: we forced the software to generate a two cluster solution
whose relative asymmetry in control/patients composition is thus a
completely unbiased (no choice of genes, no a priori driving of
solution) measure of discrimination. This analysis was followed by
a principal component analysis (PCA) of the data set.
The principal components were extracted from the same
matrix. Patients and controls are then defined in the space of
component loadings which represent different individuals in
terms of similarities in the gene expression space. The loading
space was then analysed by a linear discriminant analysis
(a supervised procedure) based on three components (two from
U133A and one from U133B space) allowing for an almost perfect
(only one misclassified unit) separation of the data set into
patients and controls. PCA defines single genes in the space of
component scores, allowing for a biological association of
components to groups of genes having the highest absolute
scores and thus permitting a biological interpretation of the
obtained discrimination.
Results
OPC analysis on the U133A data set generated an optimal two
cluster solutions of the data set exhibiting the composition in terms
of control and disease samples reported in Table 1.
The same procedure as applied to U133B set generated the
contingency table reported in Table 2.
Both the classifications are significantly related to the patient/
control discrimination scoring a Fisher’s exact test significance
equal to p,0.0001 and p,0.015 respectively.
This points to a global, genome-wide, significant discrimination
of the two groups. In order to go in depth and refining this
preliminary ‘raw’ result, we separately applied PCA to the two
U133A and U133B sets.
Tables 3 and 4 show proportional and cumulative variance
expressed by the first 10 PCs, for microarray data extracted from
chip U133A and U133B, respectively.
The first PC, for each chip, accounts for more than 98% of the
total variability so pointing to a remarkable general similarity
between samples’ profiles as evident in Fig. 1.
A lot of experimental evidences [20–21] point to the genome
regulation as the dynamics of an highly connected system that
cannot be profitably a priori factorized into single genes
independent dynamics. This connectivity is at the basis of the
consideration of cell kinds as ‘attractors’ in multidimensional
spaces constituted by the characteristic expression values of the
different genes [21]. This attractor-like (and very deterministic)
properties of gene expression hold at the cell population level,
while, at the single cell level, stochasticity seems to prevail [21].
Since the population level is the one important for our analysis
that deals with tissue properties, the analysis of the genome profiles
as a whole is of utmost importance for the description of between-
Table 1. Optimal cluster solution generated by OPC analysis
on the U133A data set.
Control AF patients
Cluster1a 15 0
Cluster2a 5 10
doi:10.1371/journal.pone.0013668.t001
Table 2. Optimal cluster solution generated by OPC analysis
on the U133B data set.
Control AF patients
Cluster1b 3 16
Cluster2b 7 4
doi:10.1371/journal.pone.0013668.t002
Table 3. Proportional and cumulative variance expressed by
the first 10 PCs, for microarray data extracted from chip
U133A.
Eigenvalue Proportionn Cumulative
1 0.9842 0.9842
2 0.0032 0.9874
3 0.0021 0.9895
4 0.0014 0.9909
5 0.001 0.9919
6 0.0009 0.9928
7 0.0007 0.9935
8 0.0007 0.9941
9 0.0006 0.9947
10 0.0005 0.9952
doi:10.1371/journal.pone.0013668.t003
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correspondent to the specific tissue and cell kind leads to between-
samples correlations close to one, as for the genome-wide
expression profile. Globally the commonality between gene
expression profiles on the genome-wide scale accounts for 98%
of total variability in both sets. This overwhelming commonality
confines the between-samples differences into minor components.
The principal component analysis (PCA) projects by construction
the initial space spanned by the different samples into a new
derived space whose axes (principal components) are each other
orthogonal. It allows for a direct, unbiased normalization of the
data field, where the ‘shared variance’ is accounted for by the first
principal component (attractor) and the minor components (from
second component onward) keep trace of the relevant among
samples differences.
The analysis of the factor loadings (FL, correlation coefficients
between original variables and components) of the first 6 PCs
revealed that the FLs which better discriminate between
permanent AF patients and controls were: FL of the 2
nd PC for
both chips (namely, FL2A and FL2B); FL of the 3
rd component of
chip A (FL3A); and FL of the 5
th component of chip B (FL5B). A
linear discriminant analysis (LDA) based on the combination of
these 4 FLs leads to the classification reported in table 5.
The classification obtained by LDA on the four selected
components space is extremely accurate with only one missed
sample.
Figure 2 shows the discrimination plane obtained combining
FL2A and FL2B. This reduced bidimensional plane does not allow
to get the same accuracy as the four dimensional one used for
LDA, but it explains the general logic of the method.
The correlation of each FL of one chip with the corresponding
FL of the other chip leads to the results reported in table 6.
Surprisingly, the FL of one chip turned out to be highly correlated
with the corresponding one of the other chip up to the 6
th PC. The
surprise comes from the fact that, even if the minor components
are more and more affected by noise [19], we found relevant
correlations for components like the sixth, which explains as few as
8 parts out of ten thousands of the global variability. It suggests an
extremely deterministic type of control. Clearly this determinism,
analogously to the strict determinism of thermodynamic laws,
arises as an average over millions of single stochastic elements
(cells). This tissue level control is probably at the basis of the organ
reliability [14,15,21]. This finding is extremely relevant consider-
ing U133A and U133B share only a minimal portion of common
genes. The fact that U133B has a larger portion of not annotated
genes than U133A is a further proof of the fact that genomes work
as a network rather than as a summation of the activities of
Table 4. Proportional and cumulative variance expressed by
the first 10 PCs, for microarray data extracted from chip
U133B.
Eigenvaluee Proportionn Cumulative
1 0.9835 0.9835
2 0.0035 0.9870
3 0.0028 0.9898
4 0.0010 0.9908
5 0.0008 0.9917
6 0.0008 0.9924
7 0.0006 0.9930
8 0.0006 0.9936
9 0.0005 0.9942
10 0.0005 0.9946
doi:10.1371/journal.pone.0013668.t004
Figure 1. The graph axes are the genome-wide profiles of two samples (an AF and a control one), the vector points are the single
genes. The overwhelming order parameter correlating around 20000 genes expression values is evident. The line roughly corresponds to PC1.
doi:10.1371/journal.pone.0013668.g001
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of the genome is an almost equivalent system.
The genes having the highest 50 scores (in module) of the
discriminant components were extracted to give a biological
meaning of the observed patient/control discrimination. Table 7
shows the genes with the highest scores (in absolute value) for the
factor loadings of the 2
nd PCs for chip U133A (FL2A).
The genes reported in gray rows are those previously found on
the same data by the group who perform the atrial biopsy in 2005,
using the classical methods of gene up- and down-expression of
patients respect to controls [10,12]. The large number of genes in
common extracted with two completely different methodologies is
a further proof of the robustness of the adopted strategy.
Looking at the biological functions of the genes most influenced
by the discriminant components we can try and give a functional
characterization to the obtained discrimination. With some
exceptions of genes specifically linked to heart functioning
(natriuretic factor), the great majority of the extracted genes
pertains to two main ‘biological classes’: genes linked to tissue
organization and heart structure and genes involved in inflam-
matory processes.
Discussion
The mechanism of AF in human tissues is extremely complex,
because atrial remodeling consists of electrical, contractile, and
structural remodeling. In addition, structural remodeling may
occur from chronic hemodynamic, metabolic, or inflammatory
stressors. The cellular and molecular basis of AF is a field of
enormous interest. Many factors such as ion channels, proteins
influencing calcium homeostasis, connexins, autonomic innerva-
tion, fibrosis, and cytokines may be involved in the molecular
mechanism of AF.
Some aspects of the molecular mechanisms underlying the
genetic variability of AF and the perioperative cardiovascular risk
have been investigated, indicating the alteration of genes involved
in oxidative stress, inflammation and coagulation [10,11,22–24].
In this paper we applied the PCA to microarray data obtained
from permanent AF patients and no-AF control group. The
underlying hypothesis of the strategy is that the AF signature in
terms of differential gene expression cannot be traced back to the
independent activation of single players (genes) but on a general
modulation of the entire genome.
Comparing our methodology with the commonly used general
supervised inferential approach (with statistical test such as SAM)
we were able to better characterized different physiopathological
aspects of AF, aspects impossible to be separately identified by a
classical supervised approach [12].
Unlike the classical meta-analysis approach [25] which tries to
identify sets of relevant genes shared by independent studies, we
abandoned the concept of the selection of important genes as main
goal of the procedure, to shift toward an unsupervised approach
centered on the elucidation of major fluxes of gene expression
correlations as defined by principal component analysis.
As expected, the first PC accounts for more than 98% of the
total population variability; the first PC can be considered as the
common substrate of each individual myocardium. The differ-
ences in gene expression profiles between permanent AF patients
and controls are related to a very small part of the data variability.
However, the analysis of such a small difference in terms of factor
loadings and scores, succeed in discriminating patients from
controls and extracting further genes involved in the pathology,
respect to those already detected. The strict deterministic
character (at the population scale) of the fine modulation
correspondent to the minor components is proven by the strong
correlations existing between partially independent gene expres-
sion panels.
A careful investigation of the genes endowed with highest scores
relative to the second component of gene expression (the only
component common to the two U133A and U133B endowed with
an elevated discriminant power) reveals groups of genes that are
involved in cardiac muscle structure and organization and in
inflammatory processes. Most of these genes are known to be
markers of the pathology, validating our approach; however, we
detect further genes involved in the pathology that allows
Table 5. Classification of patients combining FL2A, FL2B,
FL3A and FL5B by LDA.
AF Control Total
AF 10 0 10
Control 1 19 20
Total 11 19
doi:10.1371/journal.pone.0013668.t005
Figure 2. Discrimination plane obtained combining FL2A and
FL2B. The points in the plot correspond to individual patients
(N=normal patients; AF= atrial fibrillation patients). The plot is
spanned by the two most relevant discriminating factors obtained
from the two chips. The discriminating line is the result of the
application of linear discriminant analysis on the FL2A and FL2B space.
doi:10.1371/journal.pone.0013668.g002
Table 6. Correlation among the FLs of the two chips (U133A
and U133B).
FL1A FL2A FL3A FL4A FL5A FL6A
FL1B 0.70 0.01 0.38 20.39 20.21 20.12
FL2B 0.01 0.72 20.59 20.10 20.12 0.13
FL3B 0.15 20.38 20.64 20.21 20.02 0.14
FL4B 20.44 20.28 20.32 0.80 20.10 0.15
FL5B 20.26 0.18 20.14 0.31 0.75 20.23
FL6B 20.13 20.11 0.11 20.04 0.11 0.70
doi:10.1371/journal.pone.0013668.t006
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pathology studied.
It is worth noting the virtual absence of genes directly involved
in the generation of the electrical stimulus at the single ion channel
microscopic level. This is a very important point that in some way
alters the classical picture of the disease: the most relevant
information for the AF disease are located at the level of tissue
organization that in turn is linked to the stimulus conduction and
generalization on the tissue scale and not at the level of single cell
stimulus onset.
Both tissue organization [26] and inflammation [27] are well
known players in atrial fibrillation, thus our analysis gave results
consistent with the clinical evidences. It is worth noting that both
tissue organization and inflammation are systemic features hardly
decomposable into single genes contributions [17].
At this level of analysis is practically impossible to separate
‘causes’ from ‘consequences’, i.e. modifications in gene expression
that can play a role in the onset of the pathology and modifications
that are induced by the fibrillation event.
We hope further experimentation along this way could shed
light into this very important point.
Conclusion
This manuscript applies a novel approach for the processing of
microarray data of atrial tissue in persistent AF patients. This
approach allows a clear discrimination between microarray
expression profiles of persistent AF patients respect to a control
population. The analysis of genes involved in this clustering reveals
modification of microarray expression in genes involved in cardiac
muscle structure and organization and in inflammatory processes.
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